We are live on ! Find out more
ORIAU

Orion Biotech Opportunities Corp. Units
ORIAU

Delisted

ORIAU was delisted on the 25th of April, 2023.

Back to rankings

21 hedge funds and large institutions have $73.8M invested in Orion Biotech Opportunities Corp. Units in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

45% less capital invested

Capital invested by funds: $134M → $73.8M (-$60.2M)

51% less funds holding

Funds holding: 43 → 21 (-22)

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 23

Holders
21
Holders Change
-22
Holders Change %
-51.16%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
4
Reduced
7
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OAC
OMERS Administration Corp
Ontario, Canada
+$400K
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$299K
3
CCM
Context Capital Management
California
+$57.9K
4
WC
Wealthspring Capital
New York
+$40K
5
Jane Street
Jane Street
New York
+$629

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$10.1M
2
SCC
Spring Creek Capital
Kansas
-$8.04M
3
ACA
Arena Capital Advisors
California
-$6.03M
4
ACM
Atalaya Capital Management
New York
-$5.03M
5
FIG
Fortress Investment Group
New York
-$4.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Atalaya Capital Management
New York
– -$5.03M -500,000 Closed
FIG
27
Fortress Investment Group
New York
– -$4.31M -428,902 Closed
RCM
28
Radcliffe Capital Management
Pennsylvania
– -$4.02M -400,000 Closed
AGC
29
Angelo Gordon & Co
New York
– -$3.02M -300,000 Closed
Marshall Wace
30
Marshall Wace
United Kingdom
– -$2.78M -275,000 Closed
UOC
31
UBS O'Connor
Illinois
– -$2.52M -250,000 Closed
AA
32
AQR Arbitrage
Connecticut
– -$2.02M -200,000 Closed
DCM
33
DG Capital Management
New York
– -$1.77M -175,000 Closed
RCM
34
Rivernorth Capital Management
Florida
– -$1.76M -175,000 Closed
WRBC
35
W.R. Berkley Corp
Connecticut
– -$1.74M -173,095 Closed
PMAM
36
Picton Mahoney Asset Management
Ontario, Canada
– -$1.51M -150,000 Closed
SCM
37
Segantii Capital Management
Hong Kong
– -$1.51M -150,000 Closed
CH
38
CVI Holdings
Delaware
– -$1.01M -100,000 Closed
DCM
39
Dupont Capital Management
Delaware
– -$1.01M -100,000 Closed
AFM
40
Anson Funds Management
Texas
– -$754K -75,000 Closed
WA
41
Whitebox Advisors
Minnesota
– -$754K -75,000 Closed
EAM
42
Exos Asset Management
New York
– -$562K -55,685 Closed
PAM
43
Panagora Asset Management
Massachusetts
– -$136K -13,491 Closed
GT
44
Glenmede Trust
Pennsylvania
– -$120K -11,956 Closed
1
2

ORIAU Hedge Fund Activity: Q3 2021 in Review

21 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q3 2021, worth a combined $73.8M — down 45% from $134M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ORIAU and 1 opened new positions — a net loss of 22 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $400K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $10.1M sold.

  • 21 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q3 2021, down from 43 in Q2 2021.
  • Funds reported $73.8M of Orion Biotech Opportunities Corp. Units stock for Q3 2021, down 45% quarter-over-quarter.
  • 1 fund opened new Orion Biotech Opportunities Corp. Units positions in Q3 2021 and 23 closed out, a net change of -22 holders.
  • The largest Orion Biotech Opportunities Corp. Units buyer in Q3 2021 was OMERS Administration Corp, an estimated $400K added.
  • The largest Orion Biotech Opportunities Corp. Units seller in Q3 2021 was Fir Tree Capital Management, an estimated $10.1M sold.

Based on aggregated 13F filings for Q3 2021.